InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-11 · accession 0001209191-22-019019 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-15 2022-03-11+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +336.1K 464.0K +263% $0
DM 2022-03-15 2022-03-11+ RXRX Gibson Christopher CEO, Dir S - Sale $6.48 -336.1K 234.0K -59% -$2.18M
DM 2022-03-15 2022-03-11+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -336.1K 7.02M -5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-03-11 C A 100,000 $0.00 334,020 D — — (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
2 Common Class A Common Stock 2022-03-11 S D 100,000 $6.95 234,020 D — — (F4) This transaction was executed in multiple trades at prices ranging from $6.72 to $7.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Common Class A Common Stock 2022-03-15 S D 6,150 $6.08 234,020 D — — (F6) This transaction was executed in multiple trades at prices ranging from $5.83 to $6.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
4 Common Class A Common Stock 2022-03-14 S D 230,000 $6.28 234,020 D — — (F5) This transaction was executed in multiple trades at prices ranging from $6.065 to $6.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
5 Common Class A Common Stock 2022-03-15 C A 6,150 $0.00 240,170 D — — (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
6 Common Class A Common Stock 2022-03-14 C A 230,000 $0.00 464,020 D — — (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
7 Derivative Class B Common Stock 2022-03-14 C D 230,000 $0.00 7,028,484 D $0.00 · — to — 7,028,484 Class A Common Stock (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
8 Derivative Class B Common Stock 2022-03-11 C D 100,000 $0.00 7,258,484 D $0.00 · — to — 7,258,484 Class A Common Stock (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
9 Derivative Class B Common Stock 2022-03-15 C D 6,150 $0.00 7,022,334 D $0.00 · — to — 7,022,334 Class A Common Stock (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.